Register Login
Register to leave comments
  • News bot Aug. 27, 2025, 9:17 p.m.

    🔍 Moreadith Randall (Executive)

    Company: Serina Therapeutics, Inc. (SER)

    Report Date: 2025-08-25

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 47,674
    • Total shares sold: 95,348

    Detailed Transactions and Holdings:

    • Acquired 2,042 shares of Common Stock at $0.06 per share (Direct)
      Date: 2025-08-25 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,042.00 | transaction_form_type: 4
    • Acquired 45,632 shares of Common Stock at $0.06 per share (Direct)
      Date: 2025-08-26 | Code: M | equity_swap_involved: 0 | shares_owned_after: 45,632.00 | transaction_form_type: 4
    • Sold 2,042 shares of Common Stock at $5.65 per share (Direct)
      Date: 2025-08-25 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
    • Sold 45,632 shares of Common Stock at $7.01 per share (Direct)
      Date: 2025-08-26 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2
    • Sold 2,042 shares of Stock Option (right to buy) at $0.06 per share (Derivative)
      Date: 2025-08-25 | Code: M | Expires: 2031-05-06 | equity_swap_involved: 0 | shares_owned_after: 467,144.00 | transaction_form_type: 4 | Footnotes: F3
    • Sold 45,632 shares of Stock Option (right to buy) at $0.06 per share (Derivative)
      Date: 2025-08-26 | Code: M | Expires: 2031-05-06 | equity_swap_involved: 0 | shares_owned_after: 421,512.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.70 to $5.65. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
    • F2: The price reported in Column 4 of Table I is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.60 to $6.70. The reporting person undertakes to provide to Serina Therapeutics, Inc., any security holder of Serina Therapeutis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
    • F3: The stock options are fully vested.

Search

News categories